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At the earliest stage of activation, human polymorphonu-
clear neutrophils release vesicles derived directly from the cell
surface. These vesicles, called ectosomes (PMN-Ect), expose
phosphatidylserine in the outer membrane leaflet. They in-
hibit the inflammatory response of human monocyte-derived
macrophages and dendritic cells to zymosan A (ZymA) and
LPS and induce TGF-1 release, suggesting a reprogramming
toward a tolerogenic phenotype. The receptors and signaling
pathways involved have not yet been defined. Here, we demon-
strate that PMN-Ect interfered with ZymA activation of
macrophages via inhibition of NFB p65 phosphorylation and
NFB translocation. The MerTK (Mer receptor tyrosine
kinase) and PI3K/Akt pathways played a key role in this immu-
nomodulatory effect as shown using specific MerTK-blocking
antibodies and PI3K inhibitors LY294002 and wortmannin. As
a result, PMN-Ect reduced the transcription of many proin-
flammatory genes in ZymA-activated macrophages. In sum,
PMN-Ect interacted with the macrophages by activation of the
MerTK pathway responsible for down-modulation of the
proinflammatory signals generated by ZymA.
In general, intercellular communication occurs via mem-
brane contact, soluble mediators (e.g. hormones, cytokines,
chemokines), and small molecular mediators (e.g. nucleotides,
bioactive lipids, nitric oxide ions) (1–3). However, recent evi-
dence emphasizes the transfer of information by small vesi-
cles released by one cell to its target cell (4, 5). In the litera-
ture, such vesicles go by various names, including
microvesicles, nanovesicles, particles, and microparticles.
Specific vesicles released from multivesicular bodies (pre-
formed vesicles) from various cell types have been named
exosomes and best described in the immune system, where
they are capable of presenting specific antigens to T-lympho-
cytes (6, 7). Others, released at the time of cellular activation
by budding directly from the cell surface, i.e. by ectocytosis,
have been logically named ectosomes (8, 9).
Ectosomes are released by human polymorphonuclear neu-
trophils (PMN-Ect)2 at the time of cellular activation. Inter-
estingly, such ectosomes do not increase inflammatory pro-
cesses; on the contrary, they were shown to down-modulate
cellular activation of macrophages (10) and dendritic cells
(DCs) (11). In human monocyte-derived macrophages
(HMDMs), PMN-Ect could inhibit the release of TNF and
reduce the release of IL-8 and IL-10 induced by zymosan A
(ZymA) and LPS (10). When immature monocyte-derived
DCs were exposed simultaneously to PMN-Ect and LPS, their
morphology was modified, their phagocytic activity and the
expression of cell-surface markers (CD40, CD80, CD83,
CD86, and HLA-DP, -DQ, and -DR) were reduced, cytokine
release (IL-8, IL-10, IL-12, and TNF) was inhibited, and their
capacity to induce T-cell proliferation was impaired (11).
These data suggested that ectosomes induce a tolerogenic
phenotype in DCs, similar to what has been described for
apoptotic cells (ACs).
So far, the mechanisms responsible for the biological effects
of PMN-Ect remain speculative. The phosphatidylserine (PS)
exposed in the outer membrane leaflet of PMN-Ect may be a
major factor influencing macrophages and DCs, as shown for
ACs and liposomes (12–14). Similar to ACs, PMN-Ect have
been shown to induce the release of TGF-1 by macrophages
and DCs, which might be responsible for the down-regulation
of their Toll-like receptor-mediated maturation (15–17).
Recent studies revealed that TAM (Tyro3/Axl/Mer) recep-
tor tyrosine kinases bind PS and that antigen-presenting cell-
produced TAM ligands are bridging these interactions in a
calcium-dependent manner (e.g. GAS6 (growth arrest-specific
6) and Protein S) (18). TAM receptors, expressed in a large
variety of cells, including macrophages and DCs, have been
shown to have the capacity to down-modulate the inflamma-
tory response (19, 20). In vivo and in vitro studies demon-
strate that these receptors are required for AC clearance and
homeostatic regulation of the immune system (21–23). Most
of the analyses concerning ACs and TAM receptors have
been carried out with MerTK (Mer receptor tyrosine kinase).
Recently, ACs have been proposed to inhibit mouse DC acti-
vation via the induction of MerTK, which activates the PI3K/
Akt pathway and inhibits NFB (24).
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The transcription factor NFB has a major role in regulat-
ing many aspects of cellular activity, in inflammation, cell pro-
liferation, differentiation, and cell survival (25). The mamma-
lian NFB protein family consists of five proteins (p50, p52,
p65 (RelA), c-Rel, and RelB) found in homodimers and het-
erodimers (25, 26). In the cytoplasm, NFB is regulated by a
class of inhibitor proteins called IB proteins (27). Upstream
activating signals cause the phosphorylation of IB proteins
and their ubiquitination and subsequent degradation, allow-
ing NFB dimers to enter the nucleus (25, 27, 28). Once
translocated in the nucleus, NFB undergoes post-transla-
tional modifications (such as phosphorylation of the p65 sub-
unit at Ser276 and Ser536) that affect its transcriptional activa-
tion (25). Whether PMN-Ect interfere with the NFB
signaling pathway is currently undetermined. Because PMN-
Ect have immediate inhibitory effects on HMDMs and DCs
(10, 11), we investigated whether PMN-Ect modify the NFB
signaling pathways of HMDMs and whether MerTK is
involved.
EXPERIMENTAL PROCEDURES
Isolation, Culture, and Maturation of HMDMs—HMDMs
were derived from monocytes isolated from fresh buffy coats.
A buffy coat was diluted 1:1 (v/v) with Hanks’ balanced saline
solution (Invitrogen), layered over Histopaque-1077 (Sigma),
and centrifuged for 30 min at 350 g. Monocytes were recov-
ered, washed, and cultured in Dulbecco’s modified Eagle’s
medium supplemented with 1% penicillin/streptomycin and
1% L-glutamine (DMEM) for 1 h at 37 °C. After incubation,
non-adherent cells were removed by washing twice with pre-
warmed DMEM. The remaining adherent cells were then
cultured in DMEM supplemented with 10% normal human
serum. The culture was maintained in 5% CO2 at 37 °C, and
the medium was replaced on days 4 and 7. On days 7–10,
HMDMs were washed, and PMN-Ect and/or ZymA (5 g/ml
final concentration; Sigma) was added in fresh DMEM with-
out normal human serum (10).
Collection of PMN-Ect—To isolate PMNs, a fresh buffy coat
was diluted 1:1 (v/v) with PBS/EDTA (2 mM), mixed with 0.25
volume of 4% dextran T500 (GE Healthcare), and left for 30
min for erythrocyte sedimentation. Leukocyte-rich superna-
tant was aspirated and centrifuged for 10 min at 200 g. The
pellet was resuspended in 9 ml of ultrapure water to lyse
erythrocytes. Isotonicity was restored by the addition of 3 ml
of KCl (0.6 M) and 40 ml of NaCl (0.15 M). Cells were then
centrifuged for 10 min at 350 g and resuspended in 20 ml of
PBS/EDTA. This suspension was layered over 20 ml of His-
topaque-1077 and centrifuged for 30 min at 350 g. The
PMN-rich pellet was recovered and washed twice with PBS/
EDTA. All manipulations were performed at 4 °C, thus mini-
mizing PMN activation (8–11).
For stimulation, pooled PMNs (1 107 cells/ml) from
healthy blood donors were diluted 1:1 (v/v) in prewarmed
(37 °C) RPMI 1640 medium (Invitrogen) with 1 M formyl-
methionyl-leucyl-phenylalanine and incubated for 20 min at
37 °C. PMNs were removed by centrifugation (4000 g for 15
min at 4 °C), and PMN-Ect contained in the supernatant were
concentrated with Centriprep centrifugal filter devices (MW
10,000 cut-off; Millipore) and stored in aliquots at80 °C
until used (8–11).
Detection of NFB and Akt Activation—HMDMs were cul-
tured in 96-well plates for 7 days. The phosphorylation levels
of NFB p65/RelA and Akt were quantified with CASETM
cellular activation of signaling ELISA (SABiosciences) accord-
ing to the manufacturer’s instructions. In some experiments,
HMDMs were treated for 1 h at 37 °C with 20 g/ml goat
anti-MerTK antibody (Ab; AF891, R&D Systems), 20 g/ml
goat IgG Ab (R&D Systems), an isotype control, or the PI3K
inhibitor LY294002 (50 M; SABiosciences) or wortmannin
(200 nM; Calbiochem) prior to PMN-Ect and/or ZymA incu-
bation. All samples were measured in triplicates, and the re-
sults are given as an absorbance ratio of phosphorylated pro-
tein to total protein.
Western Blotting—Nuclear and cytoplasmic extracts were
prepared from HMDMs using a nuclear extract kit (Active
Motif, Rixensart, Belgium) according to manufacturer’s in-
structions. Protein concentrations were quantified using a
Bio-Rad DC protein assay kit. Proteins were separated by
SDS-PAGE and transferred to Bio-Rad Trans-Blot transfer
medium. The levels of NFB p65 were measured in the nu-
clear extracts using a 1:500 dilution of an anti-N-terminal
NFB p65 Ab (Santa Cruz Biotechnology, Heidelberg, Ger-
many). To monitor equal protein loading, blots were stripped
and reprobed with a 1:2000 dilution of an anti-TATA-binding
protein Ab (Abcam). Activation of Akt was assessed in the
cytoplasmic extracts using a 1:1000 dilution of an anti-phos-
pho-Ser473 Akt1 Ab (Millipore), and blots were then reprobed
using a 1:200 dilution of antibodies against the non-phosphor-
ylated form of Akt (Santa Cruz Biotechnology). The binding
of HRP-labeled donkey anti-rabbit or sheep anti-mouse sec-
ondary Ab (GE Healthcare) or donkey anti-goat Ab (Santa
Cruz Biotechnology) was analyzed using ECL detection re-
agents (GE Healthcare).
Fluorescence Microscopy—HMDMs were generated on
8-well culture slides (Falcon, BD Biosciences). After 7–10
TABLE 1
Primers for quantitative real-time RT-PCR
Primer Sequences
GAPDH
Forward ATTGCCCTCAACGACCACT
Reverse GCACAGGGTACTTTATTGATGG
IL-1
Forward GGGCCTCAAGGAAAAGAATC
Reverse AGCTGACTGTCCTGGCTGAT
IL-6
Forward CAGTTCCTGCAGAAAAAGGC
Reverse ATCTGAGGTGCCCATGCTAC
IL-8
Forward ACATACTCCAAACCTTTCCACCC
Reverse CAACCCTCTGCACCCAGTTTTC
IL-10
Forward CGAGATGCCTTCAGCAGAGTG
Reverse GGGAAGAAATCGATGACAGC
IL-12
Forward CATAACTAATGGGAGTTGCCTGGC
Reverse AACGGTTTGGAGGGACCTCG
TNF
Forward GAGTGACAAGCCTGTAGCCCATGTTGTAGC
Reverse GCAATGATCCCAAAGTAGACCTGCCCAGAC
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days of culture, HMDMs were washed with DMEM without
normal human serum and incubated for the indicated times
with or without ZymA in the absence or presence of PMN-
Ect labeled with FITC-CD66b (GeneTex Inc.). Then, HMDMs
were washed, fixed with 4% paraformaldehyde, and perme-
abilized with 0.1% Triton X-100 in PBS. NFB staining was
performed by incubation with an anti-NFB primary Ab
(RelA; sc-109, Santa Cruz Biotechnology), followed by a
Cy5-labeled donkey anti-rabbit secondary Ab (Jackson
ImmunoResearch Laboratories). Labeled cells were mounted
with VECTASHIELD containing DAPI (Vector Laboratories,
Burlingame, CA). Analysis was performed on an Olympus
BX61 microscope.
Quantitative Real-time RT-PCR—On day 7, HMDMs were
cultured for 45 min or 3 h alone or with PMN-Ect, ZymA, or
ZymA and PMN-Ect. After 45 min or 3 h, total RNA was iso-
lated with the NucleoSpin RNA/protein system (Macherey-
Nagel, Du¨ren, Germany) and reverse-transcribed with Molo-
ney murine leukemia virus reverse transcriptase (Promega) in
the presence of random hexamers (Promega) and de-
oxynucleoside triphosphate. The reaction mixture was incu-
bated for 5 min at 70 °C and then for 1 h at 37 °C. The reac-
tion was stopped by heating at 95 °C for 5 min. SYBR PCR was
performed based on SYBR Green fluorescence (SYBR Green
PCR Master Mix, Applied Biosystems, Foster City, CA). Prim-
ers for GAPDH, IL-1, IL-6, IL-8, IL-10, IL-12 and TNF are
shown in Table 1. The difference in the cycle threshold (CT)
value was derived by subtracting the CT value for GAPDH,
which served as an internal control, from the CT value for the
transcript of interest. All reactions were run in duplicate us-
ing an ABI 7500 sequence detection system (Applied Biosys-
tems). The mRNA expression levels of the transcripts were
calculated relative to GAPDH from the CT values using the
formula 2 CT.
Quantitation of Cytokines by ELISA—HMDM supernatants
were collected and spun at 500 g for 10 min at 4 °C to re-
move cellular debris. The concentrations of various cytokines
were measured using a human proinflammatory 7-Plex tissue
FIGURE 1. Inhibition of NFB p65 phosphorylation in ZymA-stimulated
humanmacrophages by PMN-Ect. HMDMs were incubated in medium
alone (NS) or with PMN-Ect and in medium supplemented with ZymA in the
presence or absence of PMN-Ect. At 20 and 45 min, the phosphorylation of
NFB p65 was analyzed. *, p 0.05, ZymA PMN-Ect versus ZymA. Results
are the mean S.E. of three independent experiments.
FIGURE 2. Immunofluorescence microscopy of the inhibition of NFB translocation in the nucleus by PMN-Ect in ZymA-stimulated human
macrophages. HMDMs were incubated in medium alone (A) or with PMN-Ect (B), with ZymA (C), or with ZymA  PMN-Ect (D) for 20 min. Cells were
then fixed, stained with anti-NFB primary Ab (RelA; sc-109) followed by Cy5-labeled donkey anti-rabbit secondary Ab (red), and analyzed by immu-
nofluorescence microscopy. In B and D, green dots correspond to FITC-CD66b-prelabeled PMN-Ect that are present in the cytoplasm. The imaging
medium was VECTASHIELD fluorescence mounting medium containing DAPI, and the analysis was performed on an Olympus BX61 microscope.
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culture kit (MSD, Gaithersburg, MD) according to the manu-
facturer’s instructions. All samples were measured in
duplicates.
Statistical Analysis—Data sets were tested for normality.
Parametric analysis (two-tailed paired Student’s t test) for
normally distributed data and non-parametric analysis (Wilc-
oxon matched-pairs test) for non-normally distributed data
were performed using GraphPad Prism software. Data are
expressed as the mean S.E. A p value0.05 was considered
statistically significant.
RESULTS
PMN-Ect Inhibit NFB Activation in HMDMs—As NFB is
the key transcription factor controlling major proinflamma-
tory genes, we were interested in investigating whether NFB
signaling is involved in HMDM down-modulation upon en-
countering PMN-Ect. The NFB p50/p65 dimer is typically
sequestered in the cytoplasm by its interaction with IB.
Upon stimulation, IB is phosphorylated, ubiquitinated, and
degraded, allowing the NFB dimer to enter the nucleus (25–
28). Because phosphorylation of NFB p65 at Ser536 is re-
ported to enhance its transcriptional activation (25), we mea-
sured the phosphorylation of NFB p65 in resting or
zymosan-stimulated HMDMs in the absence or presence of
PMN-Ect after 20 and 45 min (Fig. 1). PMN-Ect alone had no
effect on NFB p65 Ser536 phosphorylation. In contrast,
ZymA alone induced a significant Ser536 phosphorylation of
NFB p65 compared with resting HMDMs. Strikingly, the
effect of ZymA was significantly suppressed by PMN-Ect (p
0.05 at both 20 and 45 min; n 3). These results demonstrate
that PMN-Ect have the capacity to interfere with NFB p65
Ser536 phosphorylation at the time of HMDM stimulation,
suggesting an inhibitory effect of PMN-Ect on NFB
transactivation.
To investigate whether this reduced phosphorylation was
related to interference with the translocation of NFB to the
nucleus, we performed immunofluorescence microscopy. We
first labeled PMN-Ect with the surface marker FITC-CD66b.
We then incubated HMDMs with labeled PMN-Ect, ZymA,
or both for 20 min and probed all samples with anti-NFB
Ab. We observed that, in resting HMDMs and in the presence
of PMN-Ect alone, NFB was mainly in the cytoplasm (Fig. 2,
A and B). As expected, in ZymA-stimulated HMDMs, NFB
FIGURE 3. Inhibition of NFB p65 translocation in the nucleus in ZymA-
stimulated humanmacrophages by PMN-Ect. HMDMs were incubated in
medium alone or with PMN-Ect and in medium supplemented with ZymA
in the presence or absence PMN-Ect for 45 min. NFB p65 was detected in
nuclear extracts via Western blotting using the anti-N-terminal NFB p65
Ab. The blots were stripped and reprobed with anti-TATA-binding protein
(TBP) Ab to monitor loading. The blots are representative of three inde-
pendent experiments.
FIGURE 4. Roles of MerTK and PI3K in PMN-Ect-induced inhibition of
NFB p65 in ZymA-stimulated humanmacrophages and effect of PMN-
Ect on Akt phosphorylation in resting humanmacrophages. HMDMs
were pretreated for 1 h at 37 °C with 20 g/ml goat anti-MerTK Ab or goat
IgG Ab (A and C) or the PI3K inhibitor LY294002 (LY; 50 M) or wortmannin
(Wort; 200 nM) (B) prior to PMN-Ect and/or ZymA incubation. At 45 min, the
phosphorylation of NFB p65 (A and B) or Akt (C) was analyzed. All samples
were measured in triplicates, and the results are given as an absorbance
ratio of phosphorylated protein to total protein. *, p 0.05, ZymA PMN-
Ect versus respective ZymA; ‡, p 0.05, PMN-Ect versus respective macro-
phages alone. Results are the mean S.E. of at least three independent
experiments. D, phosphorylation of Akt in cytoplasmic extracts was deter-
mined via Western blotting using an anti-phospho-Akt Ab (pAkt). The same
blot was then reprobed for the non-phosphorylated Akt protein. The blots
are representative of three independent experiments.
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was translocated to the nucleus (Fig. 2C). When co-incubated
with ZymA and PMN-Ect, the translocation of NFB to the
nucleus was inhibited (Fig. 2D). We also determined the
NFB p65 levels in nuclear extracts of HMDMs alone or
when they were incubated with PMN-Ect, ZymA, or both for
45 min by Western blot analysis (Fig. 3). NFB p65 was poorly
detected in resting cells, but not in the presence of PMN-Ect.
Confirming our previous results, PMN-Ect abolished the
ZymA-induced nuclear translocation of NFB p65 (Fig. 3).
Collectively, these observations confirmed that PMN-Ect in-
hibit the translocation of NFB p65 to the nucleus and its
subsequent transactivation.
PMN-Ect Induce MerTK- and PI3K/Akt-dependent Inhibi-
tion of NFB—TAM receptors and, more specifically, MerTK
are involved in the uptake of ACs by antigen-presenting cells
and in the ensuing immunosuppression (18–22). Despite
many structural differences, PMN-Ect share important bio-
logical properties with ACs, including the surface expression
of PS, which might be bridged to MerTK (9–11). To deter-
mine whether PMN-Ect activate the downstream signaling via
MerTK, we pretreated HMDMs with either anti-MerTK or
control IgG Ab for 1 h and then incubated the cells with
ZymA and/or PMN-Ect for 45 min and measured NFB p65
phosphorylation. As shown in Fig. 4A, NFB p65 phosphory-
lation was highly increased in non-treated and control IgG-
treated HMDMs stimulated with ZymA, an effect that was
significantly decreased by PMN-Ect. By itself, anti-MerTK Ab
had no effect on the phosphorylation of NFB in resting or
ZymA-activated cells. However, the inhibitory activity of
PMN-Ect on ZymA-activated cells was abolished with anti-
MerTK Ab pretreatment, suggesting that MerTK is required
for the biological activity of PMN-Ect.
In a recent study, AC inhibition of mouse DC activation by
MerTK was mediated by the activation of the PI3K/Akt path-
way, which was directly responsible for blocking NFB signal-
ing (24). Moreover, activation of PI3K/Akt pathway has been
shown to negatively regulate NFB in human monocytic cells
(29). Thus, we investigated whether this pathway plays a role
in the inhibitory effects of PMN-Ect. We pretreated HMDMs
with the PI3K inhibitor LY294002 or wortmannin for 1 h and
measured NFB p65 phosphorylation after 45 min of incuba-
tion with ZymA and/or PMN-Ect. Resting or ZymA-stimu-
lated HMDMs treated with LY294002 or wortmannin showed
similar NFB p65 phosphorylation compared with their non-
treated counterparts. In contrast, LY294002 and wortmannin
abolished the inhibitory effect of PMN-Ect on ZymA-stimu-
lated HMDMs (Fig. 4B), demonstrating the involvement of
PI3K in the inhibitory pathway induced by PMN-Ect.
To investigate whether PMN-Ect have the property to in-
duce the Akt pathway even in the absence of ZymA, we mea-
sured Akt phosphorylation of HMDMs incubated with PMN-
Ect for 45 min. Interestingly, Akt phosphorylation was highly
increased in HMDMs incubated with PMN-Ect (Fig. 4, C and
D). When HMDMs were treated with either anti-MerTK or
control IgG Ab for 1 h, anti-MerTK Ab (but not IgG Ab) pre-
treatment significantly inhibited the Akt phosphorylation in
HMDMs (Fig. 4C). As expected, pretreatment of HMDMs
with LY294002 or wortmannin for 1 h blocked Akt phosphor-
ylation (data not shown). Together, these results demonstrate
that PMN-Ect have immediate inhibitory effects on ZymA-
stimulated HMDMs by MerTK and the PI3K/Akt pathway-
mediated inhibition of NFB signaling.
Analysis of Gene Expression by Real-time RT-PCR—To fur-
ther define the inhibitory activity of PMN-Ect in resting and
ZymA-stimulated HMDMs, we investigated the early gene
expression levels of six genes associated with inflammation
and the NFB signaling pathway: TNF, IL-1, IL-6, IL-8,
IL-10, and IL-12. We measured the mRNA levels of these
FIGURE 5. Analysis of genes associated with inflammation and the NFB signaling pathway by quantitative real-time RT-PCR. HMDMs were incu-
bated for 45 min or 3 h in medium alone (NS) or with PMN-Ect, ZymA, or ZymA PMN-Ect. The differential expression of TNF, IL-1, IL-6, IL-8, IL-10, and
IL-12 was measured by quantitative real-time RT-PCR. Results were normalized to non-stimulated (NS) 1. *, p 0.05, ZymA PMN-Ect versus ZymA. Re-
sults represent the mean S.E. of at least three independent experiments measured in duplicates., results at 45 min;f, results at 3 h.
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genes in HMDMs after 45 min or 3 h of incubation with or
without ZymA in the absence or presence of PMN-Ect by
quantitative real-time RT-PCR.
At 45 min, no changes in mRNA levels were detected
whether cells were or were not stimulated with ZymA in the
absence or presence of PMN-Ect. As expected, at 3 h, the
mRNA levels of TNF, IL-1, IL-6, IL-8, IL-10, and IL-12
were highly increased when HMDMs were stimulated with
ZymA (Fig. 5). Importantly, in the presence of PMN-Ect, the
mRNA levels of these genes were significantly down-modu-
lated: TNF (level related to GAPDH), 283.7 54.9 versus
126.3 33.4 (p 0.011); IL-1, 869.1 272.8 versus 538.8
239.2 (p 0.046); IL-6, 3616 698.3 versus 1517 582.9
(p 0.002); IL-8, 226.3 75.5 versus 116.6 39.5 (p
0.046); IL-10, 8.7 1.5 versus 4.6 0.6 (p 0.044); and IL-
12, 17.2 5.1 versus 10.2 3.5 (p 0.049) (Fig. 5).
Measurement of Cytokines Released in the Supernatants—
To confirm that the observations made by RT-PCR corre-
sponded with the release of cytokines, wemeasured TNF, IL-
1, IL-6, IL-10, IL-8, and IL-12p70 released in the supernatants.
At 45min, cytokine levels were under detection limits for all the
conditions (data not shown). At 3 h, the levels of all cytokines
remained unchanged whenHMDMswere incubated with PMN-
Ect compared with resting HMDMs (Fig. 6A). Compared with
HMDMs alone, secretion of each of these cytokines was up-
regulated when cells were stimulated with ZymA. However,
co-incubation of HMDMs with PMN-Ect strongly down-
modulated the release of TNF, IL-1, IL-6, IL-10, and IL-
FIGURE 6. Cytokine measurements in the supernatants of humanmacrophages. A, HMDMs were incubated for 3 h in medium alone (NS) or with PMN-
Ect, ZymA, or ZymA PMN-Ect. The concentrations of TNF, IL-1, IL-6, IL-8, IL-10, and IL-12p70 were analyzed in the supernatants. The results shown are
from one representative experiment (n 3). B, HMDMs were pretreated for 1 h at 37 °C with 20 g/ml goat anti-MerTK Ab or goat IgG Ab prior to ZymA
and PMN-Ect incubation. The concentrations of TNF, IL-1, IL-6, IL-8, IL-10, and IL-12p70 were analyzed in the supernatants. The results are shown as rela-
tive -fold increase in cytokine release. The cytokine level of HMDMs incubated with ZymA PMN-Ect 1.
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12p70 and reduced the release of IL-8 (Fig. 6A). Similar re-
sults have been obtained previously (10), thus confirming that
our RT-PCR results corresponded to protein synthesis and
release.
Moreover, we measured the same cytokines in the superna-
tants of HMDMs pretreated with either anti-MerTK or IgG
Ab for 1 h and then incubated with ZymA and/or PMN-Ect
for 3 h. In the control experiments, anti-MerTK or IgG Ab
pretreatment did not significantly modify the levels of cyto-
kines released by HMDMs alone, in the presence of PMN-Ect,
or stimulated with ZymA (data not shown). Of relevance was
that the inhibitory effects of PMN-Ect on HMDMs stimulated
with ZymA were significantly reduced by anti-MerTK Ab
compared with the control IgG Ab, although the control IgG
Ab had a slight nonspecific inhibitory activity (Fig. 6B). In
sum, these results demonstrate that PMN-Ect down-modu-
late HMDMs through the MerTK-activated PI3K/Akt path-
way, which inhibits NFB transactivation.
DISCUSSION
Whereas the involvement of PMNs in enhancing inflamma-
tion by the release of multiple mediators and enzymes has
been extensively studied, the mechanisms responsible for the
control of this reaction are less well understood. That acti-
vated PMNs release ectosomes possessing anti-inflammatory
and immunosuppressive properties toward macrophages and
DCs is a new in vitro finding, which suggests that the very
same cells known to be central in inflammation are involved
in controlling it as well (10, 11). In this study, we identified
essential signaling pathways involved in the inhibitory effect
of PMN-Ect.
PMN-Ect inhibited the NFB p65 translocation to the nu-
cleus and its phosphorylation seen in ZymA-activated HM-
DMs. This NFB blockade led to the down-regulation of the
expression of major proinflammatory genes such as TNF,
IL-1, IL-6, IL-8, IL-10, and IL-12 (Fig. 5) and logically to
their down-modulation in protein release (Fig. 6A). Similar
results were observed with DCs cultured with ACs (24); how-
ever, several studies on the down-modulation of macrophages
by ACs have reported that NFB activation was unaffected
(30–32). Importantly, in some experimental setups testing for
the effects of ACs or PS-expressing liposomes, macrophages
or DCs had to be pretreated sometimes for several hours with
ACs or PS liposomes to see an inhibitory effect on inflamma-
tory stimuli (12, 24, 31–33). In this study, PMN-Ect were
added at the same time with the stimulus, so the biological
effects of PMN-Ect were observed immediately and were not
dependent on a first phase of protein synthesis indispensable
for these AC or PS liposome effects. Thus, our results empha-
size that, despite similarities between PMN-Ect and ACs,
there are also major differences in the pathways used to
down-regulate inflammatory signals because PMN-Ect appear
to have evident immediate effects.
MerTK is centrally involved in the inhibition of NFB by
PMN-Ect as demonstrated by using a blocking Ab. Recent in
vivo and in vitro studies showed that MerTK is required for
the “tolerogenic” clearance of ACs by macrophages and DCs
(19, 21, 22, 34). PMN-Ect share PS exposure with ACs (9), and
PS may play a key role in many of the immunomodulatory
effects of both PMN-Ect and ACs. However, we do not know
how the binding occurs, and in addition to PS, many other
cell-surface components or soluble factors released by the
target cells might be involved. For instance, GAS6 secreted by
macrophages might be an efficient link to the PS exposed on
PMN-Ect (18). Evidently, other possibilities will have to be
explored, including the recently described Tim receptors (35),
which might induce additional signaling pathways responsible
for the modulation of the cellular response.
Our results showed that PMN-Ect induced inhibition of
HMDMs by MerTK-mediated activation of the PI3K/Akt
pathway, with a resulting blockade of NFB (Fig. 4). The role
of PI3K/Akt signaling was evidenced by using the specific in-
hibitors LY294002 and wortmannin. Consistent with our
findings, activation of the PI3K/Akt pathway in LPS-stimu-
lated human monocytes was shown to regulate negatively
NFB and to limit TNF and tissue factor expression (29).
Sen et al. (24) demonstrated similar results with AC-induced
inhibition of mouse DCs. Importantly, PMN-Ect alone in-
duced the phosphorylation of Akt (Fig. 4C). Thus, this inhibi-
tory pathway was induced by PMN-Ect not only when HM-
DMs were activated by ZymA but also while they were
resting, suggesting that PMN-Ect reprogram HMDMs imme-
diately whether they are exposed to a specific stimulus or not.
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